基于正确合成的聚乙烯 (聚氨) 作为生物医学领域潜在的药物输送载体的希夫基交联基基:设计和表征
Roberta Pappalardo1,2, Monica Boffito1, Claudio Cassino3
1Department of Mechanical and Aerospace Engineering, Politecnico di Torino, 10129 Turin, Italy.
ACS omega
|November 25, 2024
概括
新的聚乙 (聚乙) 形成了适应pH的基,用于药物输送. 这些可注射,自我愈合的材料在生理条件下提供持续释放和稳定性.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 药物输送系统 药物输送系统
背景情况:
- 在现场形成的水凝由于其生理稳定性,可注射性,自我愈合性和pH响应性而吸引药物输送.
- 希夫基化学为创建这种先进的水凝系统提供了一个多功能平台.
研究的目的:
- 设计和描述基于聚乙烯糖醇的新型聚乙尿 (PEUs) 用于in situ水凝形成.
- 评估开发的水凝的物理化学,质和药物释放性质.
主要方法:
- 合成一种具有主要氨基基群的高分子量PEU (SHE3350) 和一种具有化末端群的低分子量PEU (AHE1500).
- 通过混合SHE3350和AHE1500的水溶液形成水凝.
- 使用NMR光谱,风病学,胀研究和药物释放试验进行表征.
主要成果:
- 成功形成了具有高抗应变性和膨胀能力的希夫基交联液凝 (湿物重量增加了270%).
- 证明了pH值依赖的行为:在pH值5时增强吸收导致溶解,在pH值9时吸收减少.
- 一种模型药物 (FITC-dextran) 在17天内持续释放,具有pH触发释放特征.
结论:
- 基于PEU的工程水凝在药物输送方面表现出有希望的特性,包括可注射性和自我愈合性.
- 它们的pH反应性允许控制药物释放,使它们适合各种治疗应用.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


